CNR1 and hepatocellular carcinoma: To elucidate the mechanism of action, discern off-target effects, and ensure selectivity and specificity of CBD treatment in hepatocellular carcinoma, we analyzed the expression of CB1 and CB2 receptors in HepG2 cells.